Product ID |
Structure |
Product Name |
Purity |
Price |
Delete |
AS-8174 |
 |
(2-CHLORO-4-METHOXYPHENYL)ACETONITRILE |
98%
|
|
Delete |
JR6-L3518 |
 |
(S)-2-(3-fluorobenzyl)oxirane |
96%
|
|
Delete |
JR6-L6812 |
 |
1H-Pyrazol-5-ol, 1-[4-(methylsulfonyl)phenyl]-3-(trifluoromethyl)- |
96%
|
$980/1g, $2480/5g, 10g/$4480, $7980/25g |
Delete |
JR6-L6563 |
 |
2,1,3-Benzothiadiazole, 4,7-dibromo-5-nitro- |
96%
|
|
Delete |
AS-0486 |
 |
2-(Trifluoromethyl)nicotinic acid |
98%
|
|
Delete |
A1-12036 |
 |
2-Amino cyclopentanol |
>96%
|
POA/g POA/5g POA/25g |
Delete |
AS-1300 |
 |
2-Bromo-3-fluorophenol |
98%
|
|
Delete |
AS-2636 |
 |
3-BROMO-4-METHOXYANILINE |
98%
|
|
Delete |
AS-5401 |
 |
3-Cyanopyridine |
98%
|
|
Delete |
JR6-L9339 |
 |
4-(Bromomethyl)-1,2-dimethoxybenzene |
96%
|
$288/5g, $980/25g, $1980/100g, bulky available |
Delete |
AS-6847 |
 |
4-CHLOROSULFONYL-PYRIDINIUM, CHLORIDE |
98%
|
|
Delete |
AS-2051 |
 |
4-Fluoro-2-methoxyphenylboronic acid |
98%
|
|
Delete |
AS-2752 |
 |
4-FLUORO-3-HYDROXYBENZONITRILE 98 |
98%
|
|
Delete |
JR6-L8771 |
 |
4-Hepten-2-ol, 1-chloro-, [S-(Z)]- (9CI) |
96%
|
|
Delete |
AS-5759 |
 |
6-Azaindole-3-carboxaldehyde |
98%
|
|
Delete |
JR6-L6009 |
 |
6H-1,3-Dioxolo[4,5-g]pyrido[4,3-b]indole, 2,2-difluoro-7,8,9,10-tetrahydro- |
96%
|
$518/1g, $918/2g, $1980/5g |
Delete |
JR6-L4153 |
 |
Benzenebutanoic acid, 3-chloro-ß-[[(1,1-dimethylethoxy)carbonyl]amino]-4-methoxy-, (ßR)- |
96%
|
|
Delete |
JR6-L4146 |
 |
Benzenebutanoic acid, 5-chloro-ß-[[(1,1-dimethylethoxy)carbonyl]amino]-2-fluoro-, (ßR)- |
96%
|
|
Delete |
JR6-L2482 |
 |
Benzenemethanol, 3,4-difluoro-a-(trifluoromethyl)- |
96%
|
|
Delete |
JR6-L3607 |
 |
Benzenemethanol, 4-[[4-(3,5-difluorophenyl)-5-(3,4-dimethylphenyl)pentyl]thio]- |
96%
|
|
Delete |
JR6-L4851 |
 |
Cyclobutanecarbonitrile, 1-(2-chlorophenyl)- |
96%
|
|
Delete |
AS-6149 |
 |
Cyclooctapentylose |
98%
|
|
Delete |
AS-1954 |
 |
methyl 2-fluoro-3-nitrobenzoate |
98%
|
|
Delete |
AS-3179 |
 |
Phenylpropiolaldehyde |
98%
|
|
Delete |
Continue browsing products
Quote/Order
Inquiry
|